Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Obstetrics & Gynecology

Edition

30-Second Takeaway

  • For women 30–42, established hormonal and ART strategies can improve pregnancy outcomes, but live-birth certainty and safety data remain limited.
  • Prior regressed endometrial hyperplasia associates with lower live birth after frozen embryo transfer.
  • Higher prophylactic oxytocin infusion after vaginal birth reduced measured blood loss versus lower rates.

Week ending June 27, 2026

Practical evidence updates in reproductive-age care: fertility interventions, endometrial hyperplasia, obstetric trends, vaginal estrogen, and oxytocin dosing

Systematic review: fertility interventions in women aged 30–42—improved pregnancy outcomes but limited live-birth certainty

FRONTIERS IN ENDOCRINOLOGYJun 25, 2026

This systematic review synthesized 21 studies (23 records) of interventions for women aged 30–42 seeking fertility care. Hormonal therapies, selected ART strategies, surgery, lifestyle, and psychosocial programs were variably associated with improved pregnancy-related outcomes. Evidence supporting live-birth benefit was moderate at best and limited by small samples, heterogeneity, and indirectness. Safety reporting and patient-reported outcomes were sparse, limiting risk–benefit assessment for routine practice.

Regressed endometrial hyperplasia linked to lower live birth after first frozen embryo transfer

FRONTIERS IN ENDOCRINOLOGYJun 24, 2026

In a propensity-matched cohort (EH n=95, controls n=30634 matched 1:4), live birth after first FET was lower with prior regressed EH (31.6% vs 49.2%). EH patients also had lower clinical pregnancy rates and higher pregnancy loss compared with matched infertile controls. Atypical EH, prolonged progesterone, and delayed remission further reduced live-birth likelihood on regression analyses. Even after documented remission, prior EH remained a marker of increased reproductive risk and merits tailored counseling.

Age-period-cohort analysis: people aged 40–44 have higher obstetric intervention and adverse birth outcome odds

AMERICAN JOURNAL OF EPIDEMIOLOGYJun 24, 2026

APC analysis of US singleton first births (1994–2019) found age and period effects for LBW, early-term delivery, induction, and cesarean. Pregnant people aged 40–44 had higher odds of LBW (OR 1.23), ETD (OR 1.24), induction (OR 1.05), and cesarean (OR 2.28) versus the population. Odds of LBW, ETD, and induction were higher in 2019 than the study average, suggesting evolving practice patterns. Cohort effects in 2019 imply changes in management for older birthing people beyond expected age or period trends.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Discuss limited live-birth and safety certainty when counseling women 30–42 about fertility interventions.
  • In FET counseling, disclose prior EH (even if remitted) as a risk factor for lower live-birth probability.
  • Consider individualized timing and duration of progesterone in EH management; avoid assuming full remission normalizes FET outcomes.